Chronic hepatitis B with human immunodeficiency virus co-infection (Q38316): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Doença hepática caracterizada por inflamação e fibrose hepáticas causadas por mais de 6 meses de infecção pelo vírus da hepatite B e pelo vírus da imunodeficiência humana (HIV). As manifestações clínicas incluem fadiga, endurecimento da margem hepática e complicações da cirrose (atrofia muscular, ascite, esplenomegalia/hipertensão portal) e os desfechos, incluindo carcinoma hepatocelular, são piores do que para hepatite B sem infecção por HIV.
description / endescription / en
 
A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection.

Revision as of 03:17, 13 August 2026

A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection.
Language Label Description Also known as
default for all languages
1E51.00
    English
    Chronic hepatitis B with human immunodeficiency virus co-infection
    A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis B virus and with the human immunodeficiency virus (HIV). Clinical features include fatigue, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension), and outcomes, including hepatocellular carcinoma are worse than for hepatitis B without HIV infection.

      Statements